We previously reported that the MR in skin is involved in adverse skin effects, including GC‐induced epidermal atrophy and GC‐ and diabetes‐induced delayed wound closure (Farman & Rafestin‐Oblin, 2001; Jaisser & Farman, 2016). The gene discussed is NR3C2; the disease is diabetes mellitus.